NEET UG 2023: Following the announcement of the results, the Admission Committee for Professional Undergraduate Medical Courses (ACPUGMEC) will conduct the NEET 2023 counselling process in Gujarat. aaa
Serum Institute Fracas Exposes Loose Ends of India s Clinical Trial Machinery
Participants voices are missing from deliberations about how officials should address serious adverse events in clinical trials.
Representative photo: NCI/Unsplash.
Health11/Dec/2020
Bengaluru: In November, two leading Indian COVID-19 vaccine manufacturers, Bharat Biotech and Serum Institute of India (SII), found themselves embroiled in controversy. Media reports alleged that there had been a “serious adverse event” in phase 1 of Bharat Biotech’s clinical trials for Covaxin. Phase 1 tests the safety of a new drug or vaccine in human subjects for the first time.
Then, a 40-year-old man in Chennai, through a legal notice to SII, sought compensation of Rs 5 crore for an illness he alleged appeared after he participated in a clinical trial for Covishield, SII-made version of University of Oxford and AstraZeneca’s COVID-19 vaccine candidate.